B

Biocytogen Pharmaceuticals (Beijing)
2315

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$8.89B
EV
HK$9.06B
Shares Outstanding
399.40M
Beta
0.20

Wall Street View

Analyst Rating
UNDERPERFORM
Analyst Target Price
HK$11.03
P/E 2025E
39.63x
P/Revenue 2025E
3.81x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

gainify

B

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

2315

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of antibody-based drugs in the People’s Republic of China, the United States, and internationally. Its core products are YH001, a recombinant humanized ant...

Sector

Healthcare

Industry

Biotechnology

CEO

Shen, Yuelei

Employees

1,117

IPO Date

2022-09-01

Headquarters

12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Daxing District, Beijing China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.